FDA advisory panel votes on peptide products

An FDA advisory panel has voted to approve certain peptides for market distribution, sparking significant interest in the peptide industry. However, this regulatory development has simultaneously highlighted serious concerns about the widespread availability of unregulated peptide products currently in the supply chain.